Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of lenalidomide plus rituximab for Non-Hodgkin lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: University of California, Davis | Conditions: Lymphoma | Phase 2 | Status: TERMINATED